Literature DB >> 3756897

In vivo antitumor activity and in vitro cytotoxic properties of bis[1,2-bis(diphenylphosphino)ethane]gold(I) chloride.

S J Berners-Price, C K Mirabelli, R K Johnson, M R Mattern, F L McCabe, L F Faucette, C M Sung, S M Mong, P J Sadler, S T Crooke.   

Abstract

We have previously reported the cytotoxicity and antitumor activity of bis(diphenylphosphino)ethane (DPPE) and a variety of its transition metal complexes. During studies of the chemistry of a gold complex of this group [(AuCl)2(DPPE)], it was observed that this complex readily underwent ring closure on reaction with DPPE to form the tetrahedral complex [Au(DPPE)2]+. Various counterion forms (e.g., Cl-) of this cation were isolated and were found to exhibit a remarkably high stability in solution. Evaluation of [Au(DPPE)2]Cl in mice bearing i.p. P388 leukemia demonstrated that the compound produced an average of 87% increase in life span at its maximally tolerated dose (2-3 mumol/kg/day for 5 days). Activity was also seen in i.p. M5076 reticulum cell sarcoma (60% increase in life span) and s.c. mammary adenocarcinoma 16/c. Modest activity was evident in i.p. B16 melanoma and L1210 leukemia. A subline of P388 leukemia resistant to cisplatin was not cross-resistant to [Au(DPPE)2]Cl. In addition, combination therapy of [Au(DPPE)2]Cl and cisplatin against i.p. P388 demonstrated an advantage over single-agent therapy. In vitro studies of [Au(DPPE)2]Cl showed that the compound: is cytotoxic to tumor cell lines; is only minimally inhibited in its cytotoxic activity by the presence of serum; produces DNA protein cross-links and DNA strand breaks in cells; and inhibits macromolecular synthesis with a preferential inhibitory effect on protein synthesis relative to DNA and RNA synthesis. 31P nuclear magnetic resonance spectroscopy indicated that the compound is stable in the presence of serum proteins, thiols, or disulfides and that it reacts with Cu(II) resulting in the formation of a Cu(I)DPPE complex. The results of these in vivo and in vitro experiments suggest that the contrasting pharmacological profile of [Au(DPPE)2]Cl with respect to other gold(I) phosphine complexes may be related to both the kinetic stability of the complex and its stability in the presence of thiols.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3756897

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  20 in total

1.  A ribozyme specifically suppresses transformation and tumorigenicity of Ha-ras-oncogene-transformed NIH/3T3 cell lines.

Authors:  M Y Chang; S J Won; H S Liu
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

2.  Ionic rhenocene derivatives with antitumor activity.

Authors:  P Köpf-Maier; T Klapötke
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

3.  Cytotoxicity in human cancer cells and mitochondrial dysfunction induced by a series of new copper(I) complexes containing tris(2-cyanoethyl)phosphines.

Authors:  Alessandro Zanella; Valentina Gandin; Marina Porchia; Fiorenzo Refosco; Francesco Tisato; Francesca Sorrentino; Guido Scutari; Maria Pia Rigobello; Cristina Marzano
Journal:  Invest New Drugs       Date:  2010-06-22       Impact factor: 3.850

4.  Platinum(II) chloride indenyl complexes: electrochemical and biological evaluation.

Authors:  Lisa Dalla Via; Saverio Santi; Vito Di Noto; Alfonso Venzo; Enzo Agostinelli; Annarica Calcabrini; Maria Condello; Antonio Toninello
Journal:  J Biol Inorg Chem       Date:  2011-03-29       Impact factor: 3.358

5.  Antitumor properties of organometallic metallocene complexes of tin and germanium.

Authors:  P Köpf-Maier; C Janiak; H Schumann
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

Review 6.  [Cytostatic non-platinum metal complexes: new perspectives for the treatment of cancer?].

Authors:  P Köpf-Maier
Journal:  Naturwissenschaften       Date:  1987-08

7.  Ionic titanocene complexes: a new type of antitumor agent.

Authors:  P Köpf-Maier; E Neuse; T Klapötke; H Köpf
Journal:  Cancer Chemother Pharmacol       Date:  1989       Impact factor: 3.333

8.  N, N'-Olefin functionalized bis-imidazolium gold(I) salt is an efficient candidate to control keratitis-associated eye infection.

Authors:  Tapastaru Samanta; Gourisankar Roymahapatra; William F Porto; Saikat Seth; Sudipta Ghorai; Suman Saha; Jayangshu Sengupta; Octávio L Franco; Joydev Dinda; Santi M Mandal
Journal:  PLoS One       Date:  2013-03-15       Impact factor: 3.240

Review 9.  Complexes of metals other than platinum as antitumour agents.

Authors:  P Köpf-Maier
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 10.  The medicinal applications of imidazolium carbene-metal complexes.

Authors:  Khadijah M Hindi; Matthew J Panzner; Claire A Tessier; Carolyn L Cannon; Wiley J Youngs
Journal:  Chem Rev       Date:  2009-08       Impact factor: 60.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.